Consumers Urged to Avoid Using Actos and Its Generic Equivalent
After over 1000 adverse event reports, several consumer watchdog groups have urged diabetics to avoid using Actos or its generic equivalent. Many have espoused that actos use may not be worth the...
ReadAccording to FDA reports, Actos Linked to over 1000 Bladder Cancer Diagnoses
According to a recent review of FDA adverse event reports, the FDA has received over 1000 reports from individuals reporting unexplained diagnoses of bladder cancer after Actos use. This comes after...
ReadNew Study Links Actos Use to a Doubled Risk of Bladder Cancer after Two Years of Usage, Higher Risk for High Dosage Patients
According to a new study published in the British Medicine Journal which compared healthy people with patients diagnosed with bladder cancer, Actos use has been associated with an 83% increased risk...
ReadActos Bladder Cancer Lawsuits Consolidated
MDL Consolidation to eliminate duplicative discovery, prevent inconsistent pretrial rulings, and conserve the resources of the parties, their counsel and the judiciary Actos (pioglitazone) was...
Read